Invesaro

Stocks KSCP Financial statements

Financial statements

Knightscope, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Knightscope, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2021FY2021FY2022FY2023FY2024FY2025
Revenue3.343.415.6312.810.811.3
Cost of revenue4.635.468.9514.814.516.1
Gross profit-1.3-2.06-3.32-2.02-3.7-4.78
Research and development3.255.68.456.357.0612.5
Selling, general and administrative18.416.6
Selling and marketing7.31128.55.185.14
General and administrative2.794.8811.712.613.3
Operating expenses13.322.528.624.32629.1
Operating income-14.6-24.6-32-26.3-29.7-33.9
Other non-operating income-4.7-19.36.334.17-2.060.08
Pre-tax income-19.3-43.8-25.6-22.1-31.7-33.8
Income tax0000
Net income-19.3-43.8-25.6-22.1-31.7-33.8
EBITDA-13.3-23-30.3-23.9-27.1-31.3
EPS, basic-96.67-206.17-35.51-16.77-10.97-4.00
EPS, diluted-96.67-206.17-35.51-16.77-10.97-4.00
Shares, basic (weighted)0.210.220.721.322.898.46
Shares, diluted (weighted)0.210.220.721.322.898.46

Balance sheet

FY2021FY2021FY2022FY2023FY2024FY2025
Cash and equivalents7.0610.74.812.2811.120.6
Receivables0.871.191.372.091.732.14
Inventory2.562.321.82.32
Other current assets0.331.30.010.070.351.34
Total current assets8.7913.310.18.2115.126.4
Property, plant and equipment0.020.120.610.860.661.06
Lease right-of-use assets1.621.082.011.460.412.75
Goodwill1.341.921.921.92
Intangible assets2.061.561.240.92
Other non-current assets0.220.080.120.120.090.53
Total assets12.917.622.12328.241.3
Accounts payable0.231.512.461.862.812.54
Accrued liabilities0.861.192.41.160.730.46
Deferred revenue0.520.891.711.741.881.29
Short-term debt7.112.141.360.41
Total current liabilities2.6412.210.56.958.276.61
Long-term debt4.586.551.243.954.02
Lease liabilities1.130.491.310.712.81
Other non-current liabilities0.360.260.190.07
Total liabilities1443.329.915.412.413.5
Total debt4.587.118.71.243.954.02
Paid-in capital3.0530.795.7135209255
Retained earnings-69.2-114-139-161-193-227
Shareholders' equity-66.2-82.9-43.6-26.615.827.8
Total equity-66.2-82.9-43.6-26.615.827.8
Total liabilities and equity12.917.622.12328.241.3

Cash flow statement

FY2021FY2021FY2022FY2023FY2024FY2025
Net income-19.3-43.8-25.6-22.1-31.7-33.8
Depreciation and amortization1.351.551.712.362.622.56
Stock-based compensation0.521.273.542.731.711.54
Deferred income tax000
Change in receivables-0.22-0.320.18-0.720.24-0.48
Change in inventory-0.040.240.52-0.52
Change in payables-0.741.280.94-0.60.95-0.36
Cash from operations-15.2-20.1-24.1-24.2-22.5-30.3
Capital expenditures-0.12-0.11-0.46-0.04-0.65
Acquisitions-5.42
Cash from investing-0.63-2.33-9.93-5.12-3.18-2.52
Debt issued1.12
Debt repaid-2.85
Stock issued000.550.260.02
Cash from financing22.226.12826.834.542.2
Net change in cash6.453.69-6.04-2.438.849.34
Free cash flow-20.2-24.2-24.6-22.5-31
Interest paid0.77
Income taxes paid000

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.91 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin-9.9%Gross profit / revenue.
Operating margin-213.5%Operating income / revenue.
EBITDA margin-197.7%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-217.3%Pre-tax income / revenue.
Net margin-217.3%Net income / revenue.
FCF margin-205.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-200.8%Cash from operations / revenue.
Return on equity (ROE)-152.0%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-80.5%Net income / average total assets.
Return on invested capital (ROIC)-137.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue91.7%Research and development expense / revenue.
Stock-based pay / revenue6.5%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue4.2%Capital expenditures / revenue.
D&A / revenue15.8%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y4.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y26.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y27.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y75.9%Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y46.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y23.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y26.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y192.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y127.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y110.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.16xCurrent assets / current liabilities.
Quick ratio0.84x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.54x(Cash + short-term investments) / current liabilities.
Debt / equity0.14xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets7.2%Total debt / total assets.
Liabilities / assets47.1%Total liabilities / total assets.
Net debt-$4.1MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$2.4MCurrent assets - current liabilities.
Goodwill and intangibles / assets45.8%(Goodwill + intangible assets) / total assets.
Tangible book value$4.0MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.37xRevenue / average total assets.
Fixed asset turnover14.6xRevenue / average property, plant and equipment.
Inventory turnover8.48xCost of revenue / average inventory.
Days inventory43 days365 x average inventory / cost of revenue.
Receivables turnover4.64xRevenue / average receivables.
Days sales outstanding79 days365 x average receivables / revenue.
Days payables55 days365 x average accounts payable / cost of revenue.
Cash conversion cycle67 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$2.51Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$1.16Revenue / diluted weighted shares.
FCF per share-$2.37Free cash flow / diluted weighted shares.
Operating cash flow per share-$2.32Cash from operations / diluted weighted shares.
Book value per share$1.65Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.22Tangible book value / shares outstanding.
Cash per share$0.46(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$21.5MShare price x shares outstanding.
Enterprise value$17.4MMarket cap + total debt - cash - short-term investments.
P/S1.04xMarket cap / revenue.
P/B0.73xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book5.41xMarket cap / tangible book value, when positive.
EV/Sales0.84xEnterprise value / revenue.
FCF yield-197.5%Free cash flow / market cap.
Earnings yield-209.4%Net income / market cap (the inverse of P/E).
What was Knightscope, Inc.'s revenue in fiscal 2025?

Knightscope, Inc. reported revenue of $11.3M for fiscal 2025, 4.9% higher than the year before.

Was Knightscope, Inc. profitable in fiscal 2025?

No. It reported a net loss of $33.8M.

How much free cash flow did Knightscope, Inc. generate in fiscal 2025?

Cash from operations of $30.3M minus capital expenditures of $654.0K left free cash flow of -$31.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Knightscope, Inc.